The Clorox Company (NYSE:CLX) Shares Sold by World Equity Group Inc.

World Equity Group Inc. reduced its stake in The Clorox Company (NYSE:CLXFree Report) by 51.5% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 3,144 shares of the company’s stock after selling 3,342 shares during the quarter. World Equity Group Inc.’s holdings in Clorox were worth $429,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in CLX. CIBC Private Wealth Group LLC grew its holdings in shares of Clorox by 0.5% during the fourth quarter. CIBC Private Wealth Group LLC now owns 13,900 shares of the company’s stock worth $1,982,000 after buying an additional 66 shares in the last quarter. Lindbrook Capital LLC grew its holdings in shares of Clorox by 6.2% during the first quarter. Lindbrook Capital LLC now owns 1,182 shares of the company’s stock worth $181,000 after buying an additional 69 shares in the last quarter. Blue Trust Inc. grew its holdings in shares of Clorox by 14.3% during the second quarter. Blue Trust Inc. now owns 678 shares of the company’s stock worth $93,000 after buying an additional 85 shares in the last quarter. First National Bank of Omaha grew its holdings in shares of Clorox by 1.5% during the fourth quarter. First National Bank of Omaha now owns 5,975 shares of the company’s stock worth $852,000 after buying an additional 86 shares in the last quarter. Finally, Diversify Advisory Services LLC grew its holdings in shares of Clorox by 3.9% during the second quarter. Diversify Advisory Services LLC now owns 2,441 shares of the company’s stock worth $322,000 after buying an additional 92 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Down 0.4 %

Shares of NYSE CLX traded down $0.53 during trading on Friday, reaching $145.40. 926,064 shares of the stock were exchanged, compared to its average volume of 1,260,555. The business’s 50-day moving average price is $136.47 and its 200 day moving average price is $142.41. The Clorox Company has a twelve month low of $114.68 and a twelve month high of $158.89. The company has a quick ratio of 0.53, a current ratio of 0.90 and a debt-to-equity ratio of 9.73. The company has a market capitalization of $18.06 billion, a price-to-earnings ratio of 75.34, a price-to-earnings-growth ratio of 1.97 and a beta of 0.39.

Clorox Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 30th. Stockholders of record on Wednesday, August 14th will be given a dividend of $1.22 per share. This is a boost from Clorox’s previous quarterly dividend of $1.20. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.36%. The ex-dividend date of this dividend is Tuesday, August 13th. Clorox’s payout ratio is presently 252.85%.

Analysts Set New Price Targets

CLX has been the subject of a number of recent research reports. TD Cowen initiated coverage on shares of Clorox in a report on Tuesday, July 23rd. They set a “sell” rating and a $122.00 price target for the company. DA Davidson decreased their target price on shares of Clorox from $162.00 to $153.00 and set a “neutral” rating on the stock in a research report on Friday, August 2nd. Evercore ISI decreased their target price on shares of Clorox from $145.00 to $142.00 and set an “underperform” rating on the stock in a research report on Wednesday, May 1st. UBS Group decreased their target price on shares of Clorox from $164.00 to $159.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 1st. Finally, Wells Fargo & Company decreased their target price on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a research report on Wednesday, July 10th. Six analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $141.94.

Get Our Latest Research Report on Clorox

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Recommended Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.